TLG Capital

Name

TLG Capital

Legal name

TLG Capital Investments Ltd

Website

https://tlgcapital.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Private credit lending interest income: Direct interest, fees and returns earned on structured debt investments in African SMEs across AGIF I, AGIF II and other vehicles; deal sizes typically $100k–$15m annual revenue range.
2. Fund management fees (AUM-based): Recurring management fees on the Africa Growth Impact Fund I and II vehicles and other managed funds.
3. TLG Pharma pharmaceutical distribution revenue: Operating-company revenue from distributing EU-compliant branded generics (antibiotics, antimalarials, antihistamines) across West Africa; 75 million medications distributed annually.
4. Carried interest / fund performance returns: Performance-linked returns from successful exits across portfolio (50+ deals, 30+ exits historically).

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels8 records

Core offering

TLG Capital is a London-based private credit fund manager that structures and deploys bespoke debt capital (senior debt, mezzanine, quasi-equity, trade finance) into Sub-Saharan African SMEs, primarily through its Africa Growth Impact Fund (AGIF I and AGIF II) vehicles and the FCMB-TLG Naira-denominated Private Debt Fund. The firm operates TLG Pharma as a wholly-owned subsidiary distributing EU-compliant branded generic medicines across West Africa, providing an integrated private credit and value-creation platform anchored by DFI backers (IFC, Swedfund, Norfund, Bpifrance).

Product overview

TLG Capital operates as a platform of complementary private credit vehicles and operating businesses targeting Sub-Saharan African SMEs, rather than a single unified software product. Its flagship offering is the Africa Growth Impact Fund platform — comprising AGIF I (open-ended, 2016) and AGIF II (closed-ended, 2025) — providing structured debt to SMEs in healthcare, finance, and consumer sectors. The firm also operates the FCMB-TLG Private Credit Fund, Nigeria's first Naira-denominated private debt fund co-managed with FCMB Asset Management. Complementing these credit vehicles, TLG runs TLG Pharma, an operating company that distributes EU-compliant generic medicines across West Africa. Together, these offerings form an integrated private credit and value-creation platform anchored by development-finance backers including IFC, Swedfund, Norfund, and Bpifrance.

Differentiator

Problem solved

Functional benefit

Brands

• TLG Pharma: Operating subsidiary launched in 2018, distributing branded generic medicines across West Africa (headquartered in Dubai; operates in Nigeria, Benin, Togo, Guinea, Niger, Mali, Côte d'Ivoire, Republic of Congo).

Products and services

• Africa Growth Impact Fund (AGIF I) Open-ended credit fund launched in 2016 providing structured debt to African SMEs with limited access to capital. Targets 8-10%+ net annualised returns over a 1-3 year short-term lending horizon, with focus on healthcare, finance and consumer sectors and application of a Gender 2x framework. Backed by IFC, Swedfund and Bpifrance.
• Africa Growth Impact Fund II (AGIF II) Closed-ended 7-year private credit fund building on AGIF I, offering patient 3-7 year capital to African SMEs in partnership with African banks. Targets 12-14%+ net annualised returns; achieved $75 million first close in March 2025 with $200 million target by 2026, with 30% earmarked for renewable energy and environmental services supporting Net Zero transition.
• FCMB-TLG Private Credit Fund Nigeria's first Naira-denominated private debt fund, co-managed with FCMB Asset Management. 10-year closed-ended vehicle registered with the Nigerian SEC under a N100 billion programme, providing long-term local-currency debt to high-impact businesses in agriculture, healthcare, education, clean energy, transport & logistics, and technology. Backed by 19 Nigerian pension funds (Series 1 raised N10.43bn, 4.3% oversubscribed).
• TLG Pharma Wholly-owned operating subsidiary launched in 2018, headquartered in Dubai. Distributes EU-compliant branded generic medicines (antibiotics, antimalarials, antihistamines) across West Africa to replace counterfeit medicines and expand access to affordable treatment. Distributes 75 million EU-compliant medications annually across Nigeria, Benin, Togo, Guinea, Niger, Mali, Côte d'Ivoire and Republic of Congo (expanding to Senegal and Cameroon).

Named customers16 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered flagship, core and minor.

• FCMB Asset Management LimitedflagshipStrategic or Co-development PartnerCo-developer and manager of Nigeria's first Naira-denominated Private Debt Fund (FCMB-TLG). FCMB AM is the fund manager with TLG Capital providing technical support; the fund was registered with the Nigerian SEC, achieved a ₦10.43bn first series against a ₦100bn programme, and is launching Series II (up to ₦20bn).
• UK FCDO Manufacturing AfricacoreStrategic or Co-development PartnerStrategic partner providing technical support platform for portfolio companies; TLG has partnered with Manufacturing Africa to onboard BDO, McKinsey & Company, ESS and Ndarama.
• McKinsey & CompanyminorImplementation/ SI/ Consulting PartnerValue-creation partner providing consulting support to TLG portfolio companies alongside BDO, ESS and Ndarama under the Manufacturing Africa platform.
• BDOminorImplementation/ SI/ Consulting PartnerValue-creation / consulting partner for portfolio operations under the Manufacturing Africa technical support platform.
• ESS (Environmental and Social Solutions)minorImplementation/ SI/ Consulting PartnerEnvironmental and social consulting partner supporting ESG standards for portfolio companies.
• NdaramaminorImplementation/ SI/ Consulting PartnerValue-creation partner providing operational support to TLG's portfolio companies.
• Kenya Investment Authority (KenInvest)minorGTM or Marketing PartnerPublic-sector GTM partnership supporting TLG Capital's expansion into Kenya after macro headwinds, including meetings with banks and high-caliber entrepreneurs.
• Varramore Partners LimitedcoreOthersTLG Capital Investments Ltd is an appointed representative of Varramore Partners Limited, which is authorised and regulated by the UK Financial Conduct Authority — providing the regulatory hosting arrangement for TLG's UK operations.

Scale indicators18 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• GroFin: GroFin is a private credit fund manager providing growth finance to SMEs across Africa and the Middle East, with a strong impact mandate. Directly comparable to TLG Capital given overlapping target market (African SMEs with $100k–$15m revenues), local-currency financing focus, and similar fund structures backed by DFIs.
• Vantage Capital: Vantage Capital is one of Africa's largest private credit fund managers, focused on mezzanine and senior debt to mid-market companies in Southern and Sub-Saharan Africa. Comparable to TLG Capital for its African SME/mid-market debt focus, institutional LP base, and multi-fund platform.
• Symbiotics: Symbiotics is a Geneva-based impact-focused private credit platform investing via local financial intermediaries in emerging and frontier markets including Africa. Comparable to TLG Capital for the EM SME credit focus, DFI backing, and structured-debt fund vehicles.
• responsAbility Investments: responsAbility is a Zurich-based impact asset manager investing in private credit and equity across emerging markets, with significant Africa exposure. Comparable to TLG for EM SME credit, DFI-backed fund vehicles, and a similar institutional LP base.
• Acumen: Acumen is a New York-based impact investor providing patient capital to early-stage and SME businesses across Africa and South Asia. Comparable to TLG for the Africa SME impact mandate, DFI and family-office LP base, and focus on underserved markets.
• LeapFrog Investments: LeapFrog is an impact-focused PE/credit investor in emerging markets (notably Africa and Asia) serving financial services and consumer businesses. Comparable to TLG for EM impact investing, institutional LP support, and SME growth-capital strategy.
• Cordaid Investment Management: Cordaid Investment Management manages impact-focused debt and equity funds for SMEs in fragile and frontier markets including Sub-Saharan Africa. Comparable to TLG for Africa-focused SME impact investing, DFI-backed fund vehicles, and overlap in LDC/conflict-affected geographies.

Broad incumbents

• British International Investment (BII, formerly CDC): BII is the UK's development finance institution investing across Africa and South Asia via PE, debt and direct deals. Comparable to TLG for African SME/credit mandate, DFI structure, and role as a major backer of Africa-focused fund managers.
• FMO (Dutch Entrepreneurial Development Bank): FMO is the Netherlands' DFI providing debt and equity to private sector businesses in emerging markets including Sub-Saharan Africa. Comparable to TLG for SME credit focus in emerging markets, co-lending structures with local banks, and DFI LP relationships.
• Proparco (Agence Française de Développement): Proparco is the French DFI subsidiary of AFD investing in private sector projects across Africa and emerging markets. Comparable to TLG for Africa SME finance focus, partnership with Bpifrance-aligned investors, and DFI-backed fund vehicles.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments30 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TLG Capital